GNRH1 Variants in Congenital Hypogonadotropic Hypogonadism: Single-center experience and Systematic Literature Review
Objective: As GNRH1 genotype-phenotype correlation in CHH is not well-studied, we aim to describe the GNRH1 variants in our CHH cohort and present a systematic review as well as genotype-phenotype analysis of all mutation-positive cases reported in the world literature. Design: Retrospective study of GNRH1 mutation-positive patients from a western-Indian center. PRISMA guidelines-based PubMed search of published literature of all GNRH1 mutation-positive patients Setting: Academic medical center. Patient(s): Two probands from our cohort and 19 probands from the world literature. Intervention(s): None Main Outcome Measure(s): Demographic details, clinical presentation, biochemistry, imaging, treatment details, and genotypic data were recorded. Result(s): Two probands in our cohort carried two novel pathogenic biallelic GnRH variants (p.Glu24Leu, c.238-2A>G). Both had a severe reproductive phenotype. We report successful gonadotropin therapy and fertility in one proband. We included 19 probands from 12 studies after the literature review. Ten CHH probands (inclusive two from this study) with biallelic GNRH1 variants had severe reproductive phenotype, low gonadotropins levels, low/normal prolactin, normal pituitary imaging, and no extra-reproductive phenotype. Of seven biallelic variants reported, three were frameshift, two were splice-site and two were missense mutations. All of them were pathogenic/likely pathogenic without oligogenicity. Of seven monoallelic GNRH1 variants reported in eleven probands, four had non-reproductive phenotype, three were Benign/Likely Benign, four were oligogenic. Conclusion(s): GNRH1 biallelic variants lead to severe reproductive phenotype, with low gonadotropin levels without non-reproductive features or oligogenicity. However, the role of GNRH1 monoallelic variants in CHH pathophysiology for reported variants remains questionable.